Prior literature has shown a wide variation in diagnostic and therapeutic interventions in penetrating CD15; however, since the release of the NASPGHAN clinical report on internal penetrating CD in 20135 there has been improvement in standardization of care between centers. The gene discussed is FUT4; the disease is Cowden disease.